Deleted in Liver Cancer 1 (DLC1) Negatively Regulates Rho/ROCK/MLC Pathway in Hepatocellular Carcinoma

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2008 Jul 24

PMID 18648664

Citations 27

Authors

Carmen Chak-Lui Wong

Chun-Ming Wong

Frankie Chi-Fat Ko

Lo-Kong Chan

Yick-Pang Ching

Judy Wai-Ping Yam

Irene Oi-Lin Ng

Affiliations

Soon will be listed here.

Abstract

Aims: Deleted in liver cancer 1 (DLC1), a member of RhoGTPase activating protein (GAP) family, is known to have suppressive activities in tumorigenicity and cancer metastasis. However, the underlying molecular mechanisms of how DLC1 suppresses cell motility have not been fully elucidated. Rho-kinase (ROCK) is an immediate down-stream effector of RhoA in mediating cellular cytoskeletal events and cell motility. In the present study, we aimed to investigate the effects of DLC1 on Rho/ROCK signaling pathway in hepatocellular carcinoma (HCC).

Methodology/principal Findings: We demonstrated that DLC1 negatively regulated ROCK-dependent actomyosin contractility. From immunofluorescence study, we found that ectopic expression of DLC1 abrogated Rho/ROCK-mediated cytoskeletal reorganization including formation of stress fibers and focal adhesions. It also downregulated cortical phosphorylation of myosin light chain 2 (MLC2). These inhibitory events by DLC1 were RhoGAP-dependent, as RhoGAP-deficient mutant of DLC1 (DLC1 K714E) abolished these inhibitory events. In addition, from western study, DLC1 inhibited ROCK-related myosin light chain phosphatase targeting unit 1 (MYPT1) phosphorylation at Threonine 853. By examining cell morphology under microscope, we found that ectopic expression of dominant-active ROCK released cells from DLC1-induced cytoskeletal collapse and cell shrinkage.

Conclusion: Our data suggest that DLC1 negatively regulates Rho/ROCK/MLC2. This implicates a ROCK-mediated pathway of DLC1 in suppressing metastasis of HCC cells and enriches our understanding in the molecular mechanisms involved in the progression of hepatocellular carcinoma.

Citing Articles

Mechanosignaling via Integrins: Pivotal Players in Liver Fibrosis Progression and Therapy.

Sharip A, Kunz J Cells. 2025; 14(4).

PMID: 39996739 PMC: 11854242. DOI: 10.3390/cells14040266.

Deleted in liver cancer 1 suppresses the growth of prostate cancer cells through inhibiting Rho-associated protein kinase pathway.

Gong H, Chen K, Zhou L, Jin Y, Chen W Asian J Urol. 2023; 10(1):50-57.

PMID: 36721699 PMC: 9875144. DOI: 10.1016/j.ajur.2021.12.007.

Current Advances in for Gastrointestinal and Other Cancers.

He L, Zhong Z, Chen M, Liang Q, Wang Y, Tan W Front Pharmacol. 2022; 12:775084.

PMID: 35046810 PMC: 8762280. DOI: 10.3389/fphar.2021.775084.

Weighted gene co-expression network analysis identified MYL9 and CNN1 are associated with recurrence in colorectal cancer.

Qiu X, Cheng S, Xu F, Yin J, Wang L, Zhang X J Cancer. 2020; 11(8):2348-2359.

PMID: 32127961 PMC: 7052925. DOI: 10.7150/jca.39723.

DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA.

Joshi R, Qin L, Cao X, Zhong S, Voss C, Min W J Biol Chem. 2019; 295(2):645-656.

PMID: 31806702 PMC: 6956525. DOI: 10.1074/jbc.RA119.011929.

References

Vicari R, Chaitman B, Keefe D, Smith W, Chrysant S, Tonkon M . Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J Am Coll Cardiol. 2005; 46(10):1803-11. DOI: 10.1016/j.jacc.2005.07.047. View

Ng I, Liang Z, Cao L, Lee T . DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1. Cancer Res. 2000; 60(23):6581-4. View

Wong C, Yam J, Ching Y, Yau T, Leung T, Jin D . Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. Cancer Res. 2005; 65(19):8861-8. DOI: 10.1158/0008-5472.CAN-05-1318. View

Totsukawa G, Yamakita Y, Yamashiro S, Hartshorne D, Sasaki Y, Matsumura F . Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J Cell Biol. 2000; 150(4):797-806. PMC: 2175273. DOI: 10.1083/jcb.150.4.797. View

Sturge J, Wienke D, Isacke C . Endosomes generate localized Rho-ROCK-MLC2-based contractile signals via Endo180 to promote adhesion disassembly. J Cell Biol. 2006; 175(2):337-47. PMC: 2064574. DOI: 10.1083/jcb.200602125. View

Nakagawa H, Yoshioka K, Miyahara E, Fukushima Y, Tamura M, Itoh K . Intrathecal administration of Y-27632, a specific rho-associated kinase inhibitor, for rat neoplastic meningitis. Mol Cancer Res. 2005; 3(8):425-33. DOI: 10.1158/1541-7786.MCR-05-0002. View

Song L, Ye S, Wang K, Weng Y, Liang C, Sun R . [Relationship between DLC-1 expressions and metastasis in hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi. 2005; 13(6):428-31. View

Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y . Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res. 2003; 9(7):2632-41. View

Riento K, Ridley A . Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol. 2003; 4(6):446-56. DOI: 10.1038/nrm1128. View

10.

Goodison S, Yuan J, Sloan D, Kim R, Li C, Popescu N . The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res. 2005; 65(14):6042-53. PMC: 1360170. DOI: 10.1158/0008-5472.CAN-04-3043. View

11.

Ishizaki T, Naito M, Fujisawa K, Maekawa M, Watanabe N, Saito Y . p160ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions. FEBS Lett. 1997; 404(2-3):118-24. DOI: 10.1016/s0014-5793(97)00107-5. View

12.

Wong C, Lee J, Ching Y, Jin D, Ng I . Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Res. 2003; 63(22):7646-51. View

13.

Zhou X, Thorgeirsson S, Popescu N . Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene. 2003; 23(6):1308-13. DOI: 10.1038/sj.onc.1207246. View

14.

Syed V, Mukherjee K, Lyons-Weiler J, Lau K, Mashima T, Tsuruo T . Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling. Oncogene. 2005; 24(10):1774-87. DOI: 10.1038/sj.onc.1207991. View

15.

Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T . Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem. 1996; 271(34):20246-9. DOI: 10.1074/jbc.271.34.20246. View

16.

Kim T, Lee J, Kim H, Jong H, Kim T, Jung M . DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma. Biochem Biophys Res Commun. 2007; 355(1):72-7. DOI: 10.1016/j.bbrc.2007.01.121. View

17.

Liao Y, Si L, DeVere White R, Lo S . The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1. J Cell Biol. 2006; 176(1):43-9. PMC: 2063623. DOI: 10.1083/jcb.200608015. View

18.

Yamazaki D, Kurisu S, Takenawa T . Regulation of cancer cell motility through actin reorganization. Cancer Sci. 2005; 96(7):379-86. PMC: 11159066. DOI: 10.1111/j.1349-7006.2005.00062.x. View

19.

Healy K, Hodgson L, Kim T, Shutes A, Maddileti S, Juliano R . DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms. Mol Carcinog. 2007; 47(5):326-37. PMC: 2679972. DOI: 10.1002/mc.20389. View

20.

Hagerty L, Weitzel D, Chambers J, Fortner C, Brush M, Loiselle D . ROCK1 phosphorylates and activates zipper-interacting protein kinase. J Biol Chem. 2006; 282(7):4884-4893. DOI: 10.1074/jbc.M609990200. View